Deflazacort in pharma franchise in Kerala

Deflazacort in in PCD pharma franchise in Shillong

Deflazacort in in top pharma company in Nanded

Deflazacort in in pcd pharma supplier in Gurugram

Deflazacort in in phama franchise company in India
Deflazacort in in phama distributor in Gwalior

Home/Products /deflazacort-6mg-5ml-suspension

Defziff Oral Suspension

Composition : Deflazacort (6mg/5ml)

Dosage Form : Suspension

Packaging Type : With Carton

Packaging : 30ml

Price : ₹92/-

Defziff Oral Suspension is a corticosteroid formulation designed to provide effective management of various inflammatory and autoimmune conditions. With its active ingredient, deflazacort, this suspension offers a potent anti-inflammatory effect, making it suitable for treating conditions such as rheumatoid arthritis, systemic lupus erythematosus, and certain types of dermatitis. Its formulation is particularly beneficial for patients requiring a liquid form of medication, ensuring easy administration for children and individuals who may have difficulty swallowing tablets.

Deflazacort works by suppressing the immune system’s inflammatory response, thereby alleviating symptoms such as pain, swelling, and redness. It is also indicated for use in certain acute allergic reactions and as an adjunctive treatment for specific cancers. This medication allows patients to lead a more comfortable life by reducing the severity of their symptoms and improving overall quality of life.


Read More

About the Product

Defziff Oral Suspension is a corticosteroid formulation designed to provide effective management of various inflammatory and autoimmune conditions. With its active ingredient, deflazacort, this suspension offers a potent anti-inflammatory effect, making it suitable for treating conditions such as rheumatoid arthritis, systemic lupus erythematosus, and certain types of dermatitis. Its formulation is particularly beneficial for patients requiring a liquid form of medication, ensuring easy administration for children and individuals who may have difficulty swallowing tablets.

Deflazacort works by suppressing the immune system’s inflammatory response, thereby alleviating symptoms such as pain, swelling, and redness. It is also indicated for use in certain acute allergic reactions and as an adjunctive treatment for specific cancers. This medication allows patients to lead a more comfortable life by reducing the severity of their symptoms and improving overall quality of life.


side effects may include gastrointestinal disturbances, weight gain, and mood changes. Long-term use may lead to more serious complications, such as adrenal suppression or increased risk of infections. Patients should be closely monitored by healthcare providers to manage these risks effectively.

Defziff Oral Suspension is indicated for the treatment of: Inflammatory conditions like rheumatoid arthritis Autoimmune disorders (e.g., lupus, vasculitis) Allergic reactions Asthma exacerbations Inflammatory bowel disease

Consult your healthcare provider before use, especially if you have underlying health conditions or are taking other medications. In summary, Defziff Oral Suspension provides a vital treatment option for managing a variety of inflammatory and autoimmune conditions. Its convenient liquid form facilitates easier administration, particularly for younger patients or those with swallowing difficulties. Always follow the guidance of a healthcare professional when using this medication to ensure safe and effective treatment.

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation